April 2024
1. CHAVEZ-VILLA M, Ruffolo LI, Line PD, Dueland S, et al
   Emerging Role of Liver Transplantation for Unresectable Colorectal Liver Metastases.
   J Clin Oncol. 2024;42:1098-1101.
   

   >> Share

   
   March 2024
2. GORDAN JD, Kennedy EB, Abou-Alfa GK, Beal E, et al
   Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.
   J Clin Oncol. 2024 Mar 19:JCO2302745. doi: 10.1200/JCO.23.02745.
   

   >> Share

   
   January 2024
3. HUANG DQ, Hoang JK, Kamal R, Tsai PC, et al
   Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma.
   J Clin Oncol. 2024 Jan 4:JCO2300757. doi: 10.1200/JCO.23.00757.
   

   >> Share

   
   November 2023
4. WANG G, Zhuo N, Liu Z
   Nonalcoholic Fatty Liver Disease May Be an Independent, Modifiable Risk Factor for Young-Onset Digestive Tract Cancers.
   J Clin Oncol. 2023;41:5070.
   

   >> Share

   
   June 2023
5. OOSTEROM N, Gooskens SLM, Renfro LA, Perlman EJ, et al
   Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy.
   J Clin Oncol. 2023 Jun 21:JCO2202555. doi: 10.1200/JCO.22.02555.
   

   >> Share

   
   
6. PARK JH, Hong JY, Shen JJ, Han K, et al
   Increased Risk of Young-Onset Digestive Tract Cancers Among Young Adults Age 20-39 Years With Nonalcoholic Fatty Liver Disease: A Nationwide Cohort Study.
   J Clin Oncol. 2023;41:3363-3373.
   

   >> Share

   
   
7. KERMORGANT S
   Rationale for Cotargeting Hepatocyte Growth Factor and Epidermal Growth Factor Receptor in Recurrent/Metastatic Head and Neck Cancer.
   J Clin Oncol. 2023 Jun 15:JCO2300460. doi: 10.1200/JCO.23.00460.
   

   >> Share

   
   
8. LURAIN K
   Treating Cancer in People With HIV.
   J Clin Oncol. 2023 Jun 2:JCO2300737. doi: 10.1200/JCO.23.00737.
   

   >> Share

   
   May 2023
9. EL ZARIF T, Nassar AH, Adib E, Fitzgerald BG, et al
   Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.
   J Clin Oncol. 2023 May 16:JCO2202459. doi: 10.1200/JCO.22.02459.
   

   >> Share

   
   April 2023
10. LIN TA, Das A, McCaw Z, Ludmir EB, et al
    Determining the Efficacy of Pembrolizumab in Patients With Previously Treated Advanced Hepatocellular Carcinoma.
    J Clin Oncol. 2023 Apr 4:JCO2300072. doi: 10.1200/JCO.23.00072.
    

    >> Share

    
    March 2023
11. SANDHYA L, Devi Sreenivasan N, Goenka L, Dubashi B, et al
    Randomized Double-Blind Placebo-Controlled Study of Olanzapine for Chemotherapy-Related Anorexia in Patients With Locally Advanced or Metastatic Gastric, Hepatopancreaticobiliary, and Lung Cancer.
    J Clin Oncol. 2023 Mar 28:JCO2201997. doi: 10.1200/JCO.22.01997.
    

    >> Share

    
    
12. OLOFSSON BAGGE R, Nelson A, Shafazand A, All-Eriksson C, et al
    Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial).
    J Clin Oncol. 2023 Mar 20:JCO2201705. doi: 10.1200/JCO.22.01705.
    

    >> Share

    
    December 2022
13. LI SH, Mei J, Cheng Y, Li Q, et al
    Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.
    J Clin Oncol. 2022 Dec 16:JCO2201142. doi: 10.1200/JCO.22.01142.
    

    >> Share

    
    
14. YAU T, Zagonel V, Santoro A, Acosta-Rivera M, et al
    Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial.
    J Clin Oncol. 2022 Dec 13:JCO2200972. doi: 10.1200/JCO.22.00972.
    

    >> Share

    
    
15. QIN S, Chen Z, Fang W, Ren Z, et al
    Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial.
    J Clin Oncol. 2022 Dec 1:JCO2200620. doi: 10.1200/JCO.22.00620.
    

    >> Share

    
    August 2022
16. PENG Z, Fan W, Zhu B, Wang G, et al
    Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH).
    J Clin Oncol. 2022 Aug 3:JCO2200392. doi: 10.1200/JCO.22.00392.
    

    >> Share

    
    June 2022
17. BEJJANI AC, Finn RS
    Hepatocellular Carcinoma: Pick the Winner-Tyrosine Kinase Inhibitor Versus Immuno-oncology Agent-Based Combinations.
    J Clin Oncol. 2022 Jun 1:JCO2102605. doi: 10.1200/JCO.21.02605.
    

    >> Share

    
    
18. RAPHAEL MJ, Karanicolas PJ
    Regional Therapy for Colorectal Cancer Liver Metastases: Which Modality and When?
    J Clin Oncol. 2022 Jun 1:JCO2102505. doi: 10.1200/JCO.21.02505.
    

    >> Share

    
    May 2022
19. CHIANG CH, Chiang CH, Chiang CH
    Are H1-Antihistamines Associated With a Lower Risk of Hepatocellular Carcinoma?
    J Clin Oncol. 2022 May 12:JCO2200179. doi: 10.1200/JCO.22.00179.
    

    >> Share

    
    March 2022
20. SUTCUOGLU O, Ulas Kahya B, Ozdemir N, Yazici O, et al
    Can Systemic Control Be Achieved in the Treatment of Oligometastatic Hepatocellular Cancer With Hepatic Artery Infusion Fluorouracil, Leucovorin, and Oxaliplatin Treatment?
    J Clin Oncol. 2022 Mar 29:JCO2200047. doi: 10.1200/JCO.22.00047.
    

    >> Share

    
    
21. JOHNSON PJ, Pinato DJ, Kalyuzhnyy A, Toyoda H, et al
    Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma.
    J Clin Oncol. 2022 Mar 28:JCO2102373. doi: 10.1200/JCO.21.02373.
    

    >> Share

    
    
22. MEI J, Yu H, Qin L, Jia Z, et al
    FOLFOX-HAIC for Unresectable Large Hepatocellular Carcinoma: The Effectiveness Has Yet to be Determined.
    J Clin Oncol. 2022 Mar 22:JCO2102533. doi: 10.1200/JCO.21.02533.
    

    >> Share

    
    January 2022
23. SHEN YC, Hsu HC, Lin TM, Chang YS, et al
    H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection.
    J Clin Oncol. 2022 Jan 19:JCO2101802. doi: 10.1200/JCO.21.01802.
    

    >> Share

    
    December 2021
24. LYU N, Wang X, Li JB, Lai JF, et al
    Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1).
    J Clin Oncol. 2021 Dec 14:JCO2101963. doi: 10.1200/JCO.21.01963.
    

    >> Share

    
    
25. MULCAHY MF, Mahvash A, Pracht M, Montazeri AH, et al
    Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.
    J Clin Oncol. 2021;39:3897-3907.
    

    >> Share

    
    
26. TROBAUGH-LOTRARIO A, Katzenstein HM, Ranganathan S, Lopez-Terrada D, et al
    Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.
    J Clin Oncol. 2021 Dec 7:JCO2100803. doi: 10.1200/JCO.21.00803.
    

    >> Share

    
    
27. SALEM R
    Hepatic Arterial Infusion Chemotherapy for Large Hepatocellular Carcinoma: Ready for Prime Time?
    J Clin Oncol. 2021 Dec 2:JCO2102392. doi: 10.1200/JCO.21.02392.
    

    >> Share

    
    October 2021
28. LI QJ, He MK, Chen HW, Fang WQ, et al
    Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.
    J Clin Oncol. 2021 Oct 14:JCO2100608. doi: 10.1200/JCO.21.00608.
    

    >> Share

    
    September 2021
29. BOOTH CM, Berry SR
    Perioperative Chemotherapy for Resectable Liver Metastases in Colorectal Cancer: Do We Have a Blind Spot?
    J Clin Oncol. 2021 Sep 24:JCO2101972. doi: 10.1200/JCO.21.01972.
    

    >> Share

    
    
30. LENTZ RW, Messersmith WA
    Transarterial Radioembolization in Patients With Unresectable Colorectal Cancer Liver Metastases.
    J Clin Oncol. 2021 Sep 20:JCO2101993. doi: 10.1200/JCO.21.01993.
    

    >> Share

    
    
31. KANEMITSU Y, Shimizu Y, Mizusawa J, Inaba Y, et al
    Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial.
    J Clin Oncol. 2021 Sep 14:JCO2101032. doi: 10.1200/JCO.21.01032.
    

    >> Share

    
    
32. RAYSON D
    Cardio-Oncology.
    J Clin Oncol. 2021;39:2962-2963.
    

    >> Share

    
    July 2021
33. KELLEY RK, Sangro B, Harris W, Ikeda M, et al
    Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study.
    J Clin Oncol. 2021 Jul 22:JCO2003555. doi: 10.1200/JCO.20.03555.
    

    >> Share

    
    June 2021
34. QIN S, Bi F, Gu S, Bai Y, et al
    Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial.
    J Clin Oncol. 2021 Jun 29:JCO2100163. doi: 10.1200/JCO.21.00163.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share